6th EAN Congress 2020 Goes Virtual

Dear neurologists, other healthcare professionals, and neuroscientists,

Dear colleagues and friends

In the interest of the health, safety and well-being of all registered attendees, our patients and families, as well as the general public, the European Academy of Neurology (EAN) has decided to cancel all in-person attendance and face-to-face activities at the Annual Congress, of May 23-26, 2020 in Paris. This decision has been taken due to the COVID-19 Coronavirus pandemic and in full support of public authorities in Europe and the World in their effort to slow the spread of the disease.

Difficult times ask for creative and courageous solutions which may also open new avenues for a better future. We must stay positive, strong and united more than ever to come through this crisis. Accordingly, the EAN Board has decided to organize the 6th EAN Congress as Virtual Congress for May 23-26, 2020 and offer to the neurology community the possibility for education, scientific news and best practice exchange without leaving home.

The Corona pandemic is putting our society under an incredible health, emotional and economic burden. EAN has decided, with its industry partners, to make its contribution to mitigate the consequences of the pandemic in offering the on-line participation to the EAN Virtual Congress free-of-charge.

All sessions will be available on-demand for EAN members from 27 May onwards. If you have already registered for the EAN Paris 2020 Congress, your fees will be refunded.  

Details regarding the EAN Virtual Congress and registration will be announced in due course. Please do also visit our Frequently Asked Questions area.

Best wishes for good health to you, your families and your community.

Truly yours,

Claudio L. Bassetti

EAN Acting President

European Academy of Neurology

Our mission is to promote neurological excellence in Europe and across the world, leading to better patient care and outcomes. We unite 47 national societies and represent more than 45,000 neurologists to achieve this goal.

Find out more.

EAN Scientific Panel on Neurosonology: recommendations during COVID-19 pandemic

In view of the challenges of the current Corona virus (COVID-19) pandemic and with the aim of protecting both patients and ultrasound providers (physicians, sonographers, allied professionals), the European Academy of Neurology Scientific Panel on Neurosonology is issuing the following recommendations for the performance of neurosonology investigations.

Neurorehabilitation of patients with severe brain injury during the Covid-19 epidemic

EAN Scientific Panel Coma and Chronic Disorders of Consciousness

The growing emergency due to the Covid-19 pandemic has rapidly and abruptly stressed health systems in all involved countries. Post-acute rehabilitation wards are exposed to understandable pressure from intensive care units (ICU) with a progressive increase in admission requests to facilitate discharge from acute care facilities and to free valuable beds for people affected by Covid-19 related respiratory insufficiency.

Neuro-oncology during the Covid-19 pandemics: considerations for the treatment of patients with brain tumors

At present, the Covid-19 pandemic is the focus of the global community and an all-consuming threat to the health care systems all across Europe. Resources and medical staff are reallocated, and planned medical activities are delayed or cancelled.

COVID-19 expert statement

EAN Neurogenetics Scientific Panel

Headache in COVID-19 pandemic

We are experiencing an unprecedented situation that no one had imagined or prepared for which has hit Europe during a period of prosperity, and the whole world. 

Neurologists stay aware of COVID-19 brain stem involvement

EAN Scientific Panel Infectious diseases

The major clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection are due to pulmonary complications.

EAN Movement Disorders Scientific Panel recommendations for COVID-19 pandemic

The Covid-19 global pandemic is having a dramatic impact on many chronic conditions including those affecting neurological patients and among them those with movement disorders.

EAN Scientific Panel Neuroscience/Translational neurology Statement on COVID-19

While establishing guidelines or empirical therapeutic approaches, we should take advantage of advanced technologies that allow generation and utilization of a number of animal models, in order to understand the precise causes of viral infection in humans and integrate with data emerging from the clinic.

EAN Scientific Panel Muscle & NMJ disorders

Neuromuscular patients management in the COVID era

Clinical Neurophysiology provision during the COVID-19 pandemic

Coronavirus Disease 2019 (COVID-19) typically causes fever, pulmonary and respiratory symptoms as well as gastrointestinal symptoms in the form of diarrhoea.

CME Articles
European Journal of Neurology

April Issue available now

Edited by: Didier Leys
Deputy Editor: Claudia Sommer; Associate Editors: Andrew Chan, Mark Edwards, Kristl Vonck
Impact factor: 4.387

6th EAN congress

Scientific Programme

Discover the Scientific Programme of the 6th EAN Congress!


EAN 2020 goes virtual!

The EAN Board has decided to organize the 6th EAN Congress as Virtual Congress for May 23-26, 2020 and offer to the neurology community the possibility for education, scientific news and best practice exchange without leaving home.

| COVID-19

The authors of this review (2) article hypothesize that respiratory dysfunction could be explained in part by the well-known neuroinvasive potential…

| Clinical neurophysiology

Cutaneous silent period is a useful, although underestimated tool for the clinical assessment of poly neuropathy as well as other neurological…

| Neuro-oncology

Practice changing studies have been published in late 2017 and 2018 on IDH wild-type diffuse astrocytoma (the new entity of WHO 2016 classification),…